Article Versions Notes

Brenner R, Frumin Edri HT, Meirovitz A, El-Saied S, Rouvinov K, Berezhnov I, Ievko A, Turaieva S, Fenig S, Yasin NA, et al. Evaluating the Role of Chemotherapy in Addition to Radiotherapy for High-Risk Merkel Cell Carcinoma. Medical Sciences. 2026; 14(2):311. https://doi.org/10.3390/medsci14020311

Brenner, Ronen, Hanna T. Frumin Edri, Amichay Meirovitz, Sabri El-Saied, Keren Rouvinov, Ilia Berezhnov, Anna Ievko, Sofiia Turaieva, Shlomit Fenig, Nashat Abu Yasin, and et al. 2026. "Evaluating the Role of Chemotherapy in Addition to Radiotherapy for High-Risk Merkel Cell Carcinoma" Medical Sciences 14, no. 2: 311. https://doi.org/10.3390/medsci14020311

Brenner, R., Frumin Edri, H. T., Meirovitz, A., El-Saied, S., Rouvinov, K., Berezhnov, I., Ievko, A., Turaieva, S., Fenig, S., Yasin, N. A., Fenig, E., Hussany, S., Shrem, N. S., Yakobson, A., & Shalata, W. (2026). Evaluating the Role of Chemotherapy in Addition to Radiotherapy for High-Risk Merkel Cell Carcinoma. Medical Sciences, 14(2), 311. https://doi.org/10.3390/medsci14020311